From Pills to Apps: Digital Therapeutics Go-to-Market

In this episode of The Future of Consumer Marketing, host Roman Kirsch interviews Dominik Burziwoda, CEO & Founder of Perfood. Perfood develops digital therapeutics using personalized low-glycemic diets to treat lifestyle-associated diseases like type 2 diabetes and migraines. Operating in Germany's regulated healthcare system, Perfood must navigate the complex challenge of marketing to three distinct stakeholders: insurance companies as payers, medical doctors as prescribers, and patients as end users. Through their B2B market access approach, they've created a pharmaceutical-like business model that delivers digital therapy through an app, achieving patient remission rates that traditional drug therapies cannot match. Topics Discussed: Building a regulated healthcare product that serves multiple stakeholder groups simultaneously Navigating marketing restrictions and compliance requirements in the digital therapeutics space Creating personalized health solutions using continuous glucose monitoring and AI-powered food recognition Developing longer sales funnels for complex healthcare products (4-6 months conversion cycles) Balancing scientific credibility with consumer-friendly messaging Scaling digital therapeutics across multiple disease indications and international markets